|David J. Barton, Ph.D.
||The Barton lab studies picornaviruses and viral RNA replication. In collaboration with Olve Peersen at CSU, we seek to understand how structural features in the viral polymerase influence viral RNA recombination & error catastrophe. |
|Kelly Doran, Ph.D.
||My lab seeks to elucidate the mechanisms by which Group B streptococcus colonizes the vaginal tract during pregnancy and penetrates the blood-brain barrier in the newborn to cause meningitis. We use molecular genetic approaches as well as cell based and animal models to identify bacterial virulence determinants and host factors that contribute to disease progression.|
|Breck A. Duerkop, Ph.D.
||My current research focuses on intestinal bacteria and bacteriophages. We employ culture-based approaches, animal models, and computational methods to study how intestinal bacteriophages impact the interactions of bacteria with their mammalian hosts|
|Alexander Horswill, Ph.D.
||Social activities of Staphylococci and host-pathogen interactions|
|Marijke Keestra-Gounder, Ph.D.
||My research focusses on elucidating pathways of innate immunity in response to Salmonella Typhimurium and Citrobacter rodentium.|
|Laurel Lenz, Ph.D.
||We study how Listeria monocytogenes and other bacteria manipulate mammalian cell biology to establish and propagate infections.|
|Thomas E. Morrison, Ph.D.
||Molecular pathogenesis of acute and chronic disease caused by arthropod-borne viruses and protozoan parasites|
|Stefan Pukatzki, Ph.D.
||Mechanisms and consequences of microbial competition in the context of disease.|
|Dohun Pyeon, Ph.D.
||Studying tumor viruses including human papillomavirus (HPV) infection in primary keratinocytes |
|Rosemary Rochford, Ph.D.
||My lab has developed the only available pre-clinical humanized mouse model to test for hemolytic toxicity of anti-malaria drugs in the context of G6PD deficiency. We are developing this model to further study Plasmodium infection in G6PDd hosts|
|Jerome Schaack, Ph.D.
||I study human adenovirus type 5 as a gene
|Michael Schurr, Ph.D.
||The Schurr laboratory is interested in mechanisms of transcriptional regulation in bacterial pathogenesis and is focused on a Pseudomonas aeruginosa global two-component regulator, AlgZR that controls at least 155 genes. We are using transcriptional profiling, genetics, molecular biology and biochemistry to determine the genes controlled and conditions of expression used by P. aeruginosa for these regulators. |
|Linda van Dyk, Ph.D.
||The van Dyk lab investigates molecular interactions
between virus and host that impact infection and cancer. The main
projects in the lab include analysis of a virus encoded cyclin with a
host tumor suppressor protein and characterization of non-coding RNAs that regulate the innate immune response and chronic infection.|
|Andrés Vázquez-Torres, D.V.M., Ph.D.
|| Our group investigates the adaptive responses of Salmonella, E. coli and Leishmania to oxidative and nitrosative stress that make these intracellular pathogens common causes of morbidity and mortality in humans.|